FDA Setback for Hepatitis Drug
09:54 EDT 16 Aug 2012 | Wall Street Journal
Regulators dealt Idenix Pharmaceuticals a setback, placing a partial hold on further trials of its hepatitis C drug.
Original Article: FDA Setback for Hepatitis Drug
More From BioPortfolio on "FDA Setback for Hepatitis Drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
